VANCOUVER, British Columbia & NEW YORK — Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for...

VANCOUVER, British Columbia & NEW YORK — Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for...

PACB collaborates with the University Hospital of Munster, using Revio HiFi sequencing to advance research on male infertility and rare diseases in...

Construction has begun at the RNA Research and Pilot Manufacturing Facility at Macquarie University’s main campus, northwest of Sydney’s CBD, with...

Researchers at The University of Queensland are developing a comprehensive paediatric immune cell ‘atlas’ to aid in the diagnosis and treatment of...

Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...

Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...

Charles River's new alliance with Insightec to advance therapeutic development using focused ultrasound in neuroscience.

Charles River's new alliance with Insightec to advance therapeutic development using focused ultrasound in neuroscience.

Nanomaterials developer and producer First Graphene has secured funding for a collaborative research project with Swansea University to determine the...